Pag. Bonilla et al., PHENYTOIN HYPERSENSITIVITY SYNDROME WITH POSITIVE PATCH TEST - A POSSIBLE CROSS-REACTIVITY WITH AMITRIPTYLINE, Journal of investigational allergology & clinical immunology, 8(3), 1998, pp. 186-190
A 34-year-old woman, after 2 weeks of treatment with phenytoin and ami
triptyline, developed fever and cutaneous lesions consisting of a gene
ralized maculopapular rash and eosinophilia. Her biochemical data show
ed abnormal liver functions with increased levels of SGOT; SGPT; LDH,
gamma-glutamyl transpeptidase and alkaline phosphatase. The skin biops
y pattern was compatible with phenytoin drug eruption of the erythema-
multiforme-like type (lymphocytic exocytosis, isolated dyskeratotic ce
lls, vacuolation of basal cells and incontinence of pigment). The patc
h tests were positive with phenytoin (patch test biopsy showed a typic
al eczematous pattern). The patch test with amitriptyline was negative
. An oral challenge with amitriptyline showed an erythematous maculopa
pular rash. The challenge with phenytoin was not carried out because t
he previously abnormal liver function tests contraindicated the challe
nge. Although there are a few cases reported, the patch tests could be
useful for diagnosing phenytoin allergy. Cross-reactivity between phe
nytoin and amitriptyline is possible.